The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
VanEck Biotech ETF BBH
Morningstar’s Analysis BBH
Will BBH outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 70.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Amgen Inc | 16.77 | 75.0 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 10.00 | 44.7 Mil | Healthcare |
Gilead Sciences Inc | 9.18 | 41.1 Mil | Healthcare |
Regeneron Pharmaceuticals Inc | 8.56 | 38.3 Mil | Healthcare |
IQVIA Holdings Inc | 5.08 | 22.7 Mil | Healthcare |
Icon PLC | 4.50 | 20.1 Mil | Healthcare |
argenx SE ADR | 4.48 | 20.1 Mil | Healthcare |
Biogen Inc | 4.28 | 19.2 Mil | Healthcare |
Illumina Inc | 3.76 | 16.8 Mil | Healthcare |
Moderna Inc | 3.69 | 16.5 Mil | Healthcare |